Mpox: what to know
Mpox: symptoms, transmission and protection tips.
This article is up to date as of April 8, 2025, and based on vaccine guidance provided by the U.S. Centers for Disease Control and Prevention (CDC). Individual states may adopt their own vaccine policies and recommendations based on local public health assessments and regulatory frameworks. For the most up-to-date information, consult your state or local health department or your health care provider.
It seems like every year a new virus or disease makes headlines: COVID-19, RSV (respiratory syncytial virus), new flu strains and even a rise in measles. Another disease to be aware of is mpox (previously known as monkeypox). Once mostly confined to parts of Africa, recent outbreaks have brought it to new regions, including the U.S., raising questions about how it spreads and who’s most at risk.
So how can people protect themselves? Let’s break it down.
In this article:
- What is mpox?
- Why was monkeypox renamed mpox?
- Mpox symptoms: what to watch for
- How mpox spreads
- About the mpox vaccine
- Who needs the mpox vaccine?
- Mpox vaccine side effects
- Ways to help protect against mpox
- Protective gear and antibacterial supplies
- What to do if someone gets mpox
- Frequently asked questions
What is mpox?
Mpox is a viral infection caused by the monkeypox virus, which is in the same family as smallpox. While it’s generally milder than smallpox, it can still cause discomfort, and in rare cases, serious complications. The virus was originally found in western and central Africa, but a major outbreak in 2022 led to cases worldwide.
Why was monkeypox renamed mpox?
The name “monkeypox” may be misleading; the virus is believed to spread mainly through small rodents, not monkeys. It also carried harmful racial connotations and had been previously used in a discriminating way against certain groups. To help reduce the stigma, the World Health Organization (WHO) renamed it mpox.
Mpox symptoms: what to watch for
Mpox typically starts with flu-like symptoms and then develops into a rash. Here’s what to look for:
Early symptoms
- Fever
- Cough
- Chills
- Swollen lymph nodes
- Fatigue
- Muscle aches and backaches
- Headache
- Sore throat
- Nasal congestion
The rash
- Can appear on the hands, feet, face, chest or anus, or around the genitals
- Starts as pimples or blisters and progresses to scabs
- Can be painful or itchy
When someone is exposed to mpox, they may not show symptoms right away.
Symptoms usually appear within 21 days after exposure. During this time, the exposed person is contagious until all sores heal and new skin forms. New research suggests that people may be able to spread mpox to others one to four days before they even start showing symptoms. However, there isn’t any evidence that people who never had symptoms can spread the virus.
The Centers for Disease Control and Prevention (CDC) recommends that patients see a health care provider as soon as possible if they think they are sick with mpox. In most cases, mpox symptoms clear up on their own within a few weeks. However, in rare cases it can lead to serious complications or even death. Newborns, children, pregnant people and those with weakened immune systems – like from advanced human immunodeficiency virus (HIV) – are at a higher risk for severe mpox and its effects.
How mpox spreads
Mpox spreads primarily through close physical contact.
Person-to-person transmission
- Direct skin-to-skin contact with mpox rash, scabs or lesions around the anus or vagina
- Contact with bodily fluids from a person with mpox
- Prolonged face-to-face exposure (like kissing, hugging or breathing near someone)
- Sexual contact (mpox isn’t a sexually transmitted infection [STI], but intimate contact can play a role in transmission)
- From an infected parent to the fetus during pregnancy or to a newborn during and after birth
Contaminated objects and surfaces
Mpox can linger on clothing, towels, bedding and objects (e.g., electronics and sex toys) that have not been disinfected after use by someone with mpox.
Animals
The virus can spread through bites, scratches, urine, feces or flesh (from hunting, trapping or processing) from an infected animal. To reduce the risk, avoid contact with wild animals (living or dead) in areas where mpox is endemic. The Centers for Disease Control and Prevention (CDC) has a list of animals that can carry mpox.
Pets and humans can, in theory, pass mpox to each other, but there's no confirmed evidence of this transmission happening. Anyone who has or suspects they have mpox, should avoid close contact with animals, including pets, to prevent possible transmission. If a pet is thought to be infected with mpox, call a veterinarian for further guidance. For more details, visit the CDC for signs and symptoms in pets.
About the mpox vaccine
Jynneos is the recommended vaccine for the current mpox outbreak in the U.S. It’s given in two doses, spaced four weeks apart, either before or after exposure. It's about 75 percent effective after one dose and 80 to 86 percent after two doses.
Who needs the mpox vaccine?
Although anyone can get mpox, the CDC doesn’t currently recommend routine vaccination for the general public. Instead, vaccination is recommended only for certain higher-risk groups:
- LGBTQ+ individuals with an additional risk factor: Gay, bisexual and other men who have sex with men who were recently diagnosed with an STI (chlamydia, gonorrhea or syphilis) or who have more than one sexual partner.
- Contact with an infected person: Someone who has mpox or a recent sexual partner diagnosed with mpox.
- Travelers to high-risk areas: Check the CDC’s website for countries with ongoing outbreaks.
- People engaging in high-risk sexual behaviors: Having multiple sexual partners, visiting commercial sex venues (bath houses or sex clubs) or engaging in sex related to a large event (raves or festivals) in areas with ongoing mpox cases.
- Occupational risk: for exposure to orthopoxviruses (certain laboratory and health care workers).
Schedule an appointment in person or online today to receive the mpox vaccine at a nearby CVS Pharmacy location or a health care provider.
Vaccine side effects
Side effects usually appear soon after vaccination, but some people might not experience any at all.
Injection site side effects may include the following:
- Skin redness (erythema)
- Pain
- Skin swelling caused by fluid buildup
- Itchiness
- Darkened patches or spots on the skin (hyperpigmentation)
- Thickening or hardening of the skin (induration)
Whole-body side effects may include the following:
- Fatigue
- Headache
- Muscles aches and pains
- Nausea
- Chills
- Fever
According to the CDC, getting an mpox infection following two vaccine doses is rare. If it does happen, the infection is usually milder. There is a small chance someone will have a severe allergic reaction to Jynneos, so be sure to check the full ingredient list.
Ways to help protect against mpox
- People at risk should get vaccinated.
- Avoid close contact with people who have mpox.
- Wash hands regularly with soap and water.
- Disinfect shared surfaces and personal items.
- See a health care provider if symptoms appear.
The CDC has guidelines on cleaning and disinfecting when someone has mpox. Anyone with mpox or taking care of someone who has it should wear protective gear like face masks and gloves and use antibacterial sprays to help prevent the spread of the virus.
Protective gear and antibacterial supplies
Gloves create a barrier between germs and hands.
Face masks help reduce the risk of spreading mpox.
Disinfectant cleaning products help remove germs from surfaces.
Cleansing soaps help clean hands.
Hand sanitizer is convenient for times when soap and water aren't available.
What to do if someone gets mpox
Most people with mpox recover in two to four weeks without intervention. In the meantime, a few simple precautions can help prevent the virus from spreading to other people:
- Monitor symptoms and rest at home.
- Wash hands often, especially before and after touching the rash.
- Disinfect frequently touched surfaces.
- When around others, cover lesions and wear a mask.
- Avoid scratching the rash.
- Keep the infected area clean and dry.
- Isolate from others until fully recovered.
Frequently asked questions
Mpox is considered rare but has spread to many countries worldwide. For the latest case numbers, visit the CDC outbreak dashboard.
While mpox usually isn’t life-threatening, the risk of severe illness or death varies depending on health care access and underlying conditions, such as advanced HIV.
People who receive both doses of the Jynneos vaccine are protected for at least five years.
Anyone with an unexplained rash — especially inside their mouth or around their genital area — should consider getting tested. Only a health care provider can order the test, though, as no at-home options are available. For more information, contact a health care provider.
According to a CDC study, the mpox virus can remain on objects and surfaces in a household for at least 15 days.
Some health insurance plans may cover the cost of the Jynneos vaccine. Individuals should check with their insurance provider to see if they're covered.
People who have had mpox before are likely protected from getting it again. Boosters generally aren't needed if someone has had both doses of the vaccine, unless they have an occupational hazard for mpox.
No. Mpox isn’t strictly an STI because it can spread through close, skin-to-skin contact, not just through sex.
Vaccine availability varies by state based on regulations. Age restrictions apply. Available when a certified immunizer is on duty.
This content is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment. Consult your health care provider if you have any questions about medications, vitamins or supplements you may be considering or changes to your wellness or health care routines.
-
FOR RECENT OUTBREAKS SOURCE: Centers for Disease Control and Prevention. Mpox in the United States and around the world: current situation. Published May 14, 2025.
-
FOR IN THE SAME FAMILY AS SMALLPOX SOURCE: Centers for Disease Control and Prevention. About mpox. Published April 30, 2025.
-
FOR SERIOUS COMPLICATIONS SOURCE: Centers for Disease Control and Prevention. Smallpox-monkeypox vaccine VIS. Published February 28, 2025.
-
FOR ORIGINALLY FOUND SOURCE: Moore MJ, Rathish B, Zahra F. Mpox (monkeypox). StatPearls. National Library of Medicine. Published May 3, 2023.
-
FOR MAJOR OUTBREAK SOURCE: World Health Organization. Multi-country monkeypox outbreak in non-endemic countries. Published May 21, 2022.
-
FOR SPREAD MAINLY THROUGH SMALL RODENTS SOURCE: Centers for Disease Control and Prevention. About mpox. Published April 30, 2025.
-
FOR HARMFUL RACIAL CONNOTATIONS SOURCE: World Health Organization. WHO recommends new name for monkeypox disease. Published November 28, 2022.
-
FOR USED IN A DISCRIMINATING WAY SOURCE: Peter Hermann. The Washington Post. Police: assailants used slur and referenced monkeypox in Shaw attack. Published August 9, 2022.
-
FOR RENAMED IT MPOX SOURCE: World Health Organization. WHO recommends new name for monkeypox disease. Published November 28, 2022.
-
FOR HOW MPOX SYMPTOMS EVOLVE SOURCE: Centers for Disease Control and Prevention. Signs and symptoms of mpox. Published September 12, 2024.
-
FOR EARLY SYMPTOMS SOURCE: Centers for Disease Control and Prevention. Signs and symptoms of mpox. Published September 12, 2024.
-
FOR RASH SYMPTOMS SOURCE: Centers for Disease Control and Prevention. Signs and symptoms of mpox. Published September 12, 2024.
-
FOR MAY NOT SHOW SYMPTOMS SOURCE: Centers for Disease Control and Prevention. Signs and symptoms of mpox. Published September 12, 2024.
-
FOR SYMPTOMS USUALLY APPEAR WITHIN 21 DAYS SOURCE: Centers for Disease Control and Prevention. Signs and symptoms of mpox. Published September 12, 2024.
-
FOR CONTAGIOUS UNTIL ALL SORES HEAL SOURCE: World Health Organization. Mpox. Published October 16, 2024.
-
FOR ONE TO FOUR DAYS SOURCE: Centers for Disease Control and Prevention. Signs and symptoms of mpox. Published September 12, 2024.
-
FOR PEOPLE WHO HAVE NEVER HAD SYMPTOMS SOURCE: Centers for Disease Control and Prevention. How mpox spreads. Published January 30, 2025.
-
FOR SEE A HEALTH CARE PROVIDER AS SOON AS POSSIBLE SOURCE: Centers for Disease Control and Prevention. What to do if you are sick. Published January 30, 2025.
-
FOR SYMPTOMS CLEAR UP WITHIN A FEW WEEKS SOURCE: Centers for Disease Control and Prevention. What to do if you are sick. Published JANUARY 30, 2025.
-
FOR SERIOUS COMPLICATIONS SOURCE: World Health Organization. Mpox. Published: October 16, 2024.
-
FOR AT HIGHER RISK SOURCE: World Health Organization. Mpox. Published October 16, 2024.
-
FOR PERSON-TO-PERSON TRANSMISSION SOURCE: Centers for Disease Control and Prevention. How mpox spreads. Published January 30, 2025.
-
FOR CONTAMINATED OBJECTS SOURCE: Centers for Disease Control and Prevention. How mpox spreads. Published January 30, 2025.
-
FOR ANIMALS SOURCE: Centers for Disease Control and Prevention. How mpox spreads. Published January 30, 2025.
-
FOR PETS AND HUMANS SOURCE: Centers for Disease Control and Prevention. Mpox in animals and pets. Published September 12, 2024.
-
FOR CALL VETERINARIAN SOURCE: Centers for Disease Control and Prevention. Mpox in animals and pets. Published September 12, 2024.
-
FOR RECOMMENDED VACCINE SOURCE: Centers for Disease Control and Prevention. Interim clinical considerations for use of vaccine for mpox prevention in the United States. Published February 14, 2025.
-
FOR JYNNEOS ADMINISTRATION SOURCE: Centers for Disease Control and Prevention. Interim clinical considerations for use of vaccine for mpox prevention in the United States. Published February 14, 2025.
-
FOR VACCINE EFFECTIVENESS SOURCE: Centers for Disease Control and Prevention. Interim clinical considerations for use of vaccine for mpox prevention in the United States. Published February 14, 2025.
-
FOR ANYONE CAN GET MPOX SOURCE: World Health Organization. Mpox. Published October 16, 2024.
-
FOR CDC VACCINE RECOMMENDATION SOURCE: Centers for Disease Control and Prevention. Interim clinical considerations for use of vaccine for mpox prevention in the United States. Published February 14, 2025.
-
FOR HIGHER-RISK GROUPS SOURCE: Centers for Disease Control and Prevention. Mpox vaccination. Published April 16, 2025.
-
FOR ONGOING OUTBREAKS SOURCE: Centers for Disease Control and Prevention. Clade I Mpox Outbreak Originating in Central Africa. Updated May 14, 2025.
-
FOR SIDE EFFECTS USUALLY APPEAR SOURCE: Centers for Disease Control and Prevention. Interim clinical considerations for use of vaccine for mpox prevention in the United States. Published February 14, 2025.
-
FOR INJECTION SITE SIDE EFFECTS SOURCE: Food and Drug Administration. Fact sheet for recipients and caregivers about Jynneos (smallpox and mpox vaccine, live, non-replicating) to prevent mpox disease in individuals determined to be at high risk for mpox infection. Updated December 2024.
-
FOR WHOLE-BODY SIDE EFFECTS SOURCE: Food and Drug Administration. Fact sheet for recipients and caregivers about Jynneos (smallpox and mpox vaccine, live, non-replicating) to prevent mpox disease in individuals determined to be at high risk for mpox infection. Updated December 2024.
-
FOR INFECTION IS RARE SOURCE: Centers for Disease Control and Prevention. Interim Clinical Considerations for Use of Vaccine for Mpox Prevention in the United States. Updated February 14, 2025.
-
FOR INFECTION IS USUALLY MILDER SOURCE: Food and Drug Administration. Fact sheet for recipients and caregivers about JYNNEOS (smallpox and mpox vaccine, live, non-replicating) to prevent mpox disease in individuals determined to be at high risk for mpox infection. Updated December 2024.
-
FOR ALLERGIC REACTION TO JYNNEOS SOURCE: Food and Drug Administration. Fact sheet for recipients and caregivers about Jynneos (smallpox and mpox vaccine, live, non-replicating) to prevent mpox disease in individuals determined to be at high risk for mpox infection. Updated December 2024.
-
FOR TO HELP PROTECT AGAINST MPOX SOURCE: Centers for Disease Control and Prevention. Preventing mpox. Published December 11, 2024.
-
FOR GUIDELINES ON CLEANING SOURCE: Centers for Disease Control and Prevention. Cleaning and disinfecting. Updated November 20, 2024.
-
FOR PROTECTIVE GEAR SOURCE: Centers for Disease Control and Prevention. Isolation and infection control at home. Published September 13, 2024.
-
FOR RECOVER IN TWO TO FOUR WEEKS SOURCE: Centers for Disease Control and Prevention. What to do if you are sick. Published January 30, 2025.
-
FOR HELP PREVENT THE VIRUS FROM SPREADING SOURCE: Centers for Disease Control and Prevention. What to do if you are sick. Published January 30, 2025.
-
FOR MPOX IS CONSIDERED RARE SOURCE: Centers for Disease Control and Prevention. Mpox in the United States and Around the World: Current Situation Updated May 14, 2025.
-
FOR OUTBREAK DASHBOARD SOURCE: Centers for Disease Control and Prevention. Mpox in the United States and Around the World: Current Situation Updated May 14, 2025.
-
FOR RISK OF SEVERE ILLNESS OR DEATH SOURCE: World Health Organization. Mpox. Published October 16, 2024.
-
FOR PROTECTED FOR AT LEAST FIVE YEARS SOURCE: Centers for Disease Control and Prevention. Interim clinical considerations for use of vaccine for mpox prevention in the United States. Published February 14, 2025.
-
FOR UNEXPLAINED RASH SOURCE: World Health Organization. Testing for mpox: individuals and communities. Published December 11, 2023.
-
FOR ONLY A HEALTH CARE PROVIDER CAN ORDER A TEST SOURCE: Centers for Disease Control and Prevention. Getting tested for mpox. Published September 12, 2024.
-
FOR AT LEAST 15 DAYS SOURCE: Morgan CN, Whitehill F, Doty JB, et al. Environmental Persistence of Monkeypox Virus on Surfaces in Household of Person with Travel-Associated Infection, Dallas, Texas, USA, 2021. Emerging Infectious Diseases. Published October 2022.
-
FOR PLANS MAY COVER THE COST SOURCE: Assistant Secretary for Health (ASH). Mpox (formerly monkeypox). U.S. Department of Health and Human Services. Published February 4, 2025.
-
FOR LIKELY PROTECTED FROM GETTING IT AGAIN SOURCE: Centers for Disease Control and Prevention. Interim clinical considerations for use of vaccine for mpox prevention in the United States. Published February 14, 2025.
-
FOR BOOSTERS GENERALLY AREN’T NEEDEDSOURCE: Centers for Disease Control and Prevention. Mpox vaccination. Published February 14, 2025.
-
FOR MPOX ISN’T AN STI SOURCE: Fischer, RS. How does monkeypox spread? An epidemiologist explains why it isn’t an STI and what counts as close contact. The Conversation. Published August 8, 2022.
You may also like
-
Published: May 12, 2025 | 8 minutes to read
-
Updated: August 20, 2024 | 8 minutes to read
-
Published: May 23, 2025 | 6 minutes to read